TSHA 1.85 (+0%)
US8776191061BiotechnologyBiotechnology

Taysha Gene Therapies (TSHA) Stock Highlights

1.85 | +0%
2024-12-21 05:58:14
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. It is advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs. Its product candidates include TSHA-101, TSHA-118, TSHA-102, TSHA-103, and TSHA-104.

Statistics

Range Today
1.8 1.93
Volume Today 6.16M
Range 1 Year
1.19 4.32
Volume 1 Year 711.16M
Range 3 Year
0.5 14.91
Volume 3 Year 1.41B
Range 10 Year
0.5 33.35
Volume 10 Year 1.46B

Highlights

Market Capitalization 307.42M (small)
Floating Shares 122.28M
Current Price 1.85
Price To Earnings -2.73
Price To Revenue 14.99
Price To Book 2.77
Earnings Per Share -0.52
Payout Ratio 0%

Performance

Latest 0%
1 Month -12.74%
3 Months -15.91%
6 Months -36.86%
1 Year +18.59%
3 Years -87.43%
5 Years -91.68%
10 Years -91.68%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.